Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 12 studies | 43% ± 22% | |
GABAergic neuron | 5 studies | 44% ± 17% | |
neuron | 4 studies | 23% ± 8% | |
granule cell | 4 studies | 35% ± 10% | |
interneuron | 4 studies | 30% ± 9% | |
retinal bipolar neuron | 3 studies | 26% ± 9% | |
ON-bipolar cell | 3 studies | 36% ± 16% | |
rod bipolar cell | 3 studies | 48% ± 20% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 11 studies | 33% ± 21% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 89% | 749.72 | 2347 / 2642 | 40% | 1.42 | 283 / 705 |
spleen | 87% | 270.94 | 210 / 241 | 0% | 0 | 0 / 0 |
ovary | 5% | 5.24 | 9 / 180 | 29% | 0.67 | 124 / 430 |
adrenal gland | 6% | 9.26 | 16 / 258 | 23% | 0.99 | 52 / 230 |
thymus | 6% | 3.98 | 36 / 653 | 18% | 0.77 | 108 / 605 |
stomach | 11% | 18.70 | 40 / 359 | 2% | 0.04 | 5 / 286 |
skin | 0% | 0 | 0 / 1809 | 13% | 1.07 | 60 / 472 |
uterus | 4% | 3.16 | 7 / 170 | 6% | 0.14 | 26 / 459 |
liver | 9% | 8.01 | 21 / 226 | 0% | 0.00 | 1 / 406 |
kidney | 6% | 5.64 | 5 / 89 | 1% | 0.03 | 10 / 901 |
prostate | 4% | 3.45 | 10 / 245 | 1% | 0.01 | 3 / 502 |
breast | 0% | 0.71 | 2 / 459 | 3% | 0.07 | 37 / 1118 |
esophagus | 0% | 0.58 | 7 / 1445 | 2% | 0.07 | 4 / 183 |
intestine | 1% | 0.81 | 10 / 966 | 1% | 0.01 | 6 / 527 |
bladder | 0% | 0 | 0 / 21 | 2% | 0.04 | 9 / 504 |
pancreas | 0% | 0 | 0 / 328 | 2% | 0.22 | 3 / 178 |
lung | 0% | 0.12 | 1 / 578 | 1% | 0.03 | 15 / 1155 |
blood vessel | 1% | 1.24 | 15 / 1335 | 0% | 0 | 0 / 0 |
adipose | 1% | 0.50 | 8 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 1% | 0.88 | 6 / 929 | 0% | 0 | 0 / 0 |
heart | 0% | 0.16 | 2 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0015012 | Biological process | heparan sulfate proteoglycan biosynthetic process |
GO_0015014 | Biological process | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process |
GO_0030210 | Biological process | heparin biosynthetic process |
GO_0005575 | Cellular component | cellular_component |
GO_0000139 | Cellular component | Golgi membrane |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0015016 | Molecular function | [heparan sulfate]-glucosamine N-sulfotransferase activity |
GO_0102140 | Molecular function | heparan sulfate N-deacetylase activity |
GO_0019213 | Molecular function | deacetylase activity |
Gene name | NDST3 |
Protein name | Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 3 (Glucosaminyl N-deacetylase/N-sulfotransferase 3) (NDST-3) (hNDST-3) (N-heparan sulfate sulfotransferase 3) (N-HSST 3) [Includes: Heparan sulfate N-deacetylase NDST3 (EC 3.-.-.-); [heparan sulfate]-glucosamine N-sulfotransferase NDST3 (EC 2.8.2.8)] |
Synonyms | HSST3 UNQ2544/PRO4998 |
Description | FUNCTION: Essential bifunctional enzyme that catalyzes both the N-deacetylation and the N-sulfation of glucosamine (GlcNAc) of the glycosaminoglycan in heparan sulfate. Modifies the GlcNAc-GlcA disaccharide repeating sugar backbone to make N-sulfated heparosan, a prerequisite substrate for later modifications in heparin biosynthesis. Has high deacetylase activity but low sulfotransferase activity. . |
Accessions | ENST00000296499.6 [O95803-1] O95803 |